Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gourisankar Degala
Observed name:
Gourisankar P. Degala
Observed institutions:
Henry Ford Health,
Henry Ford Hospital
OpenAlex ID:
A5000135779
Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection
2023
·
Matthew D. Sims
, Sahil Khanna
, et al.
·
JAMA Network Open
·
83
PDF
Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI
2024
·
Colleen S. Kraft
, Matthew Sims
, et al.
·
Infectious Diseases and Therapy
·
9
PDF
Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI
2024
·
Colleen S. Kraft
, Matthew Sims
, et al.
·
Infectious Diseases and Therapy
PDF
959 A Large Cohort Study of the Relationship Between Hyperparathyroidism and Pancreatitis
2008
·
Gourisankar Degala
, Fadi Antaki
, et al.
·
Gastroenterology
M1144 Extra-Intestinal Manifestations As Predictors of Colorectal Cancer in Ulcerative Colitis
2008
·
Ihab Hammoud
, Gourisankar Degala
, et al.
·
Gastroenterology
A Case of Large Hookworm Infestation
2007
·
Gourisankar P. Degala
, Osama Alaradi
·
The American Journal of Gastroenterology
Show more works
View as search
Works count:
6
Citation count:
92
H-index:
2
I10-index:
1
Year
Topic
Type
